Accesso
Dott. SIMONE BISCAGLIA
 
Data di nascita: 13/12/1983 Qualifica: DIRIGENTE MEDICO
Reparto: CARDIOLOGIA Numero di telefono dell'ufficio:
Fax dell'ufficio: E-Mail: s.biscaglia@ospfe.it
 
Titolo di studio:
Specialista in malattie dell’apparato cardiovascolare conseguito presso l'Università di Ferrara in data 22/05/2015 con voto di 50/50 e lode
 
Altri titoli di studio/professionali:
Laurea Specialistica in Medicina e Chirurgia conseguita presso l'Università di Bologna in data 18/09/2008 con voto di 110/110 e lode
 
Esperienze professionali (incarichi):
Da Luglio 2015 a Marzo 2016 assegnista di ricerca presso l'Università di Ferrara e Dirigente Medico presso l'Azienda Ospedaliero-Universitaria di Ferrara
Competenze linguistiche:
Ottima conoscenza della lingua inglese.
Competenze nell'uso delle tecnologie:
Svolge attività di Cardiologo Interventista presso Centro hub ad elevato volume di procedure e con servizio di angioplastica primaria per l'infarto attivo h24. Specializzato in tecniche di imaging intracoronarico avanzato (IVUS, IVUS/NIRS, OCT) e tecniche di valutazione funzionale (FFR).  
Attività didattica:
Durante l'assegno di ricerca ha svolto attività didattica presso: il Corso di Laurea di Medicina e Chirurgia, il Corso di Laurea in Tecniche di radiologia medica, per immagini e radioterapia e il Corso di Laurea in Scienze Motorie dell'Università di Ferrara
Attività scientifica:
Autore in numerosi articoli scientifici pubblicati su giornali cardiologici internazionali "peer-reviewed" e coautore di libri incentrati su cardiologia interventistica e scompenso cardiaco. Elenco delle pubblicazioni scientifiche: 1. Gargiulo G, Costa F, Ariotti S, Biscaglia S, Campo G, Esposito G, Leonardi S, Vranckx P, Windecker S, Valgimigli M. Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-month or 24-month DAPT duration: insights from the PRODIGY trial. Am Heart Journal 2016, In press. 2. Biscaglia S, Ugo F, Ielasi A, Secco GG, Durante A, D’Ascenzo F, Cerrato E, Balghith M, Pasquetto G, Penzo C, Fineschi M, Bonechi F, Templin C, Menozzi M, Aquilina M, Rognoni A, Capasso P, Di Mario C, Brugaletta S, Campo G. Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: a Propensity-Matched Comparison(the UNDERDOGS study). Int J Cardiol. Jan 2016;208:40-5. 3. Tebaldi M, Biscaglia S, Pecoraro A, Fineschi M, Campo G. Fractional flow reserve implementation in daily clinical practice: A European survey. Int J Cardiol. 2016 Mar 15;207:206-7. PMID: 26803245 4. Biscaglia S, Campo G,·Pavasini R,·Tebaldi M,·Tumscitz C,·Ferrari R. Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry, Platelets. Jan 2016, In press. 5. Tebaldi M, Biscaglia S, Fineschi M, Manari A, Menozzi M, Secco GG, Di Lorenzo E, D'Ascenzo F, Fabbian F, Tumscitz C, Ferrari R, Campo G. Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study). Catheter Cardiovasc Interv. 2015 Dec 31. doi: 10.1002/ccd.26364. [Epub ahead of print] PubMed PMID: 26717890. 6. Pavasini R, Biscaglia S, d'Ascenzo F, Franco AD, Contoli M, Zaraket F, Guerra F, Ferrari R, Campo G. Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis. COPD. 2015 Dec 17:1-6. [Epub ahead of print] PubMed PMID: 26678708. 7. Campo G, Menozzi M, Guastaroba P, Vignali L, Belotti LM, Casella G, Berti E, Solinas E, Guiducci V, Biscaglia S, Pavasini R, De Palma R, Manari A. Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network. Eur Heart J Acute Cardiovasc Care. 2015 Oct 9. pii: 2048872615610867. [Epub ahead of print] PubMed PMID: 26452668. 8. Biscaglia S, Campo G, Tebaldi M, Tumscitz C, Pavasini R, Fileti L, Secco GG, Di Mario C, Ferrari R. Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison. Int J Cardiovasc Imaging. 2015 Sep 1. [Epub ahead of print] PubMed PMID: 26323356. 9. Biscaglia S, Ceconi C, Malagù M, Pavasini R, Ferrari R. Uric acid and coronary artery disease: An elusive link deserving further attention. Int J Cardiol. 2015 Aug 8. pii: S0167-5273(15)30315-6. doi: 10.1016/j.ijcard.2015.08.086. [Epub ahead of print] Review. PubMed PMID: 26318389. 10. Tebaldi M, Campo G, Biscaglia S. Fractional flow reserve: Current applications and overview of the available data. World J Clin Cases. 2015 Aug 16;3(8):678-81. doi: 10.12998/wjcc.v3.i8.678. PubMed PMID: 26301228; PubMed Central PMCID: PMC4539407. 11. Pavasini R, d'Ascenzo F, Campo G, Biscaglia S, Ferri A, Contoli M, Papi A, Ceconi C, Ferrari R. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis. Int J Cardiol. 2015 Jul 15;191:187-93. doi: 10.1016/j.ijcard.2015.05.006. Epub 2015 May 6. PubMed PMID: 25965630. 12. Campo G, Pavasini R, Biscaglia S, Ferri A, Andrenacci E, Tebaldi M, Ferrari R. Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study. Pharmacol Res. 2015 Jul;97:1-6. doi: 10.1016/j.phrs.2015.03.020. Epub 2015 Apr 3. PubMed PMID: 25846253. 13. Biscaglia S, Ferri A, Pavasini R, Campo G, Ferrari R. Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. J Atheroscler Thromb. 2015;22(5):535-41. doi: 10.5551/jat.29371. Epub 2015 Apr 3. PubMed PMID: 25843116. 14. Crimi G, Leonardi S, Costa F, Ariotti S, Tebaldi M, Biscaglia S, Valgimigli M. Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial. Catheter Cardiovasc Interv. 2015 Jul;86(1):E19-27. doi: 10.1002/ccd.25822. Epub 2015 Feb 20. PubMed PMID: 25703119. 15. Campo G, Pavasini R, Malagù M, Mascetti S, Biscaglia S, Ceconi C, Papi A, Contoli M. Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management. Cardiovasc Drugs Ther. 2015 Apr;29(2):147-57. doi: 10.1007/s10557-014-6569-y. PubMed PMID: 25645653. 16. Biscaglia S, Secco GG, Tumscitz C, Di Mario C, Campo G. Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system. Int J Cardiol. 2015 Mar 1;182:1-3. doi: 10.1016/j.ijcard.2014.12.103. Epub 2014 Dec 28. PubMed PMID: 25590956. 17. Campo G, Lunghi B, Pavasini R, Ferraresi P, Punzetti S, Malagù M, Biscaglia S, Ferrari R, Bernardi F. Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. Int J Cardiol. 2014 Oct 12;177(2):711-713. 18. Tumscitz C, Pirani L, Tebaldi M, Campo G, Biscaglia S. Seven french radial artery access for PCI: a prospective single-center experience. Int J Cardiol. 2014 Oct 20;176(3):1074-5. 19. Valgimigli M, Biscaglia S. Stable angina pectoris. Curr Atheroscler Rep. 2014 Jul;16(7):422. Review. 20. Vranckx P, Leonardi S, Tebaldi M, Biscaglia S, Parrinello G, Rao SV, Mehran R, Valgimigli M. Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial. Eur Heart J. 2014 Oct 1;35(37):2524-9. 21. Valgimigli M, Campo G, Penzo C, Tebaldi M, Biscaglia S, Ferrari R; Should intervention through RADial approach be denied to patients with negative Allen’s test Results? (RADAR) Investigators. Trans-Radial Coronary Catheterization and Intervention Across the Whole Spectrum of Allen's test Results. J Am Coll Cardiol. 2014 May 13;63(18):1833-41. 22. Campo G, Tebaldi M, Vranckx P, Biscaglia S, Tumscitz C, Ferrari R, Valgimigli M. Short vs. Long Term Duration of Dual Antiplatelet Therapy in Patients treated for In-stent Restenosis. A PRODIGY Trial substudy. J Am Coll Cardiol. 2014 Feb 18;63(6):506-12. 23. Biscaglia S, Tebaldi M, Vranckx P, Campo G, Valgimigli M. Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention. J Thromb Haemost. 2013 Jan;11(1):192-4. 24. Biscaglia S, Valgimigli M. Transradial coronary intervention in STEMI patients. The current status of this approach and future perspectives on its staying power. Cardiac Interventions Today May/June 2012: 58-62. 25. Biscaglia S, Valgimigli M.Trans-radial coronary approach in patients with ST-segment elevation myocardial infarction: state of the art and future perspectives. Revista Argentina de Cardioangiología Intervencionista. Septiembre - Diciembre 2012; Año 3 - Número 4: 205-210. Libri Coautore di “Heart Failure 150 Questions & Answers” book; Servier 2011. Valgimigli M., Biscaglia S. Distal protection & thrombectomy, chapter number 12 part III, PERCUTANEOUS INTERVENTIONAL CARDIOVASCULAR MEDICINE THE PCR-EAPCI TEXTBOOK 2012.
Interessi clinici e/o scientifici:
Cardiologia Interventistica, sindromi coronariche acute, imaging intracoronarico avanzato, device per il trattamento della cardiopatia ischemica.